Bentham Science Logo

Track Your Manuscript:


Current Pharmaceutical Biotechnology

Volume 21, 15 Issues, 2020
ISSN: 1873-4316 (Online)
ISSN: 1389-2010 (Print)
This journal supports open access

Contents

Current Pharmaceutical Biotechnology, Volume 12 - Number 6




Therapeutic Approaches to the Challenge of Neuronal Ceroid Lipofuscinoses

, 12(6): 867 - 883

R. Kohan, I. A. Cismondi, A. M. Oller-Ramirez, N. Guelbert, V. Tapia Anzolini, G. Alonso, S. E. Mole, R. Dodelson de Kremer and I. Noher de Halac


DOI: 10.2174/138920111795542633







Mucopolysaccharidosis Type IVA (Morquio A Disease): Clinical Review and Current Treatment: A Special Review

, 12(6): 931 - 945

S. Tomatsu, A. M. Montano, H. Oikawa, Daniel J. Rowan, M. Smith, L. Barrera, Y. Chinen, M. M. Thacker, W. G. Mackenzie, Y. Suzuki and T. Orii


DOI: 10.2174/138920111795542615



Recent Advances in Treatment Approaches of Mucopolysaccharidosis VI

, 12(6): 956 - 972

Roberto Giugliani, Clarissa Gutierrez Carvalho, Silvani Herber and Louise Lapagesse de Camargo Pinto


DOI: 10.2174/138920111795542688



Editor-in-Chief

Nikolaos Labrou
Department of Biotechnology
Agricultural University of Athens
Athens
(Greece)

Biography
View Full Editorial Board

COPE Compliant

Journal History

Current Pharmaceutical Biotechnology was launched in 2000. Dr. Nikolaos Labrou serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.97

Advertisement

How to write and publish your papers in high impact journalsOctober Health DaysPLANNING YOUR RESEARCH TO PUBLISH IN HIGH IMPACT JOURNALSCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog